Association of Pancreatic Steatosis with Metabolic Dysfunction Associated Steatohepatitis Using Magnetic Resonance Imaging
14 Oct 2025, 4 p.m.
Publication date: Available online 13 October 2025Source: PancreatologyAuthor(s): Rishi Das, ...
The COVID-19 pandemic has changed life for everyone with major changes to the way we currently live our lives. The promise of hope is on the horizon with better understanding of the virus and the roll out of the vaccine. For people with underlying health conditions, COVID-19 has caused further anxiety. For some groups, there has been guidance on who is at risk. For people with pancreatitis, there has been no specific guidance and therefore calculating the risks associated with COVID-19 is difficult.
Overall, pancreatitis is not listed as one of the conditions noted as leading to a status of clinically extremely vulnerable (CEV) in the UK however it is not as simple as this and individual circumstances need to be assessed.
To read more about this area of research please follow the link below
Chronic Pancreatitis and COVID-19
By Dr John Leeds, Consultant Pancreaticobiliary Physician, Freeman Hospital, Newcastle Upon Tyne, UK. Dr Clare Leeds, Consultant Occupational Health Physician, County Durham and Darlington NHS Foundation Trust, UK.
![]() |
![]() |